Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reducing Opioid Use/Misuse Through Better Pain Control and Active Pill Dispensing
NCT04414917Phase 2Suspended
- Sponsor
- Rutgers University
- Start
- Nov 2026
- Primary completion
- Nov 2029
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine + epinephrine in postoperative pain, sponsored by Rutgers University. Started Nov 2026; status: suspended.
02
Drugs
lidocaine + epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04414917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414917.